Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Non Operating Income: 2023-2025

Historic Non Operating Income for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$1.4 million.

  • Camp4 Therapeutics' Non Operating Income fell 2235.48% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $415,000, marking a year-over-year decrease of 40.88%. This contributed to the annual value of $1.3 million for FY2024, which is 49.88% down from last year.
  • Camp4 Therapeutics' Non Operating Income amounted to -$1.4 million in Q3 2025, which was down 428.34% from $441,000 recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Non Operating Income high stood at $755,000 for Q4 2024, and its period low was -$1.4 million during Q3 2025.
  • Moreover, its 3-year median value for Non Operating Income was $441,000 (2025), whereas its average is $195,444.
  • Within the past 5 years, the most significant YoY rise in Camp4 Therapeutics' Non Operating Income was 404.14% (2025), while the steepest drop was 2,235.48% (2025).
  • Over the past 3 years, Camp4 Therapeutics' Non Operating Income (Quarterly) stood at $486,000 in 2023, then skyrocketed by 55.35% to $755,000 in 2024, then slumped by 2,235.48% to -$1.4 million in 2025.
  • Its Non Operating Income was -$1.4 million in Q3 2025, compared to $441,000 in Q2 2025 and $667,000 in Q1 2025.